Impact of cumulative cisplatin dose in childhood nasopharyngeal carcinoma based on neoadjuvant chemotherapy response in the intensity-modulated radiotherapy era: a real-world study

BACKGROUND: We aimed to comprehensively investigate the optimal cumulative cisplatin dose during concurrent chemoradiotherapy (CC-CCD) for locoregionally advanced nasopharyngeal carcinoma (CA-LANPC) with different tumor responses after neoadjuvant chemotherapy (NAC). METHODS: Patients with CA-LANPC...

Descripción completa

Detalles Bibliográficos
Autores principales: Jin, Ya-Nan, Qiang, Meng-Yun, Liu, Meng-Meng, Cheng, Zhi-Bin, Zhang, Wang-Jian, Ryan, Ian, Marks, Tia, Yao, Ji-Jin, Xia, Liang-Ping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Primary Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8588629/
https://www.ncbi.nlm.nih.gov/pubmed/34772421
http://dx.doi.org/10.1186/s12935-021-02281-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8588629/
https://www.ncbi.nlm.nih.gov/pubmed/34772421
http://dx.doi.org/10.1186/s12935-021-02281-4

Ejemplares similares